312. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination.

BACKGROUND: A wide array of assays to detect the serologic response to SARS-CoV-2 have been developed since the emergence of the pandemic. The majority of these are either qualitative or semi-quantitative, detect antibodies against one antigenic target, and are not adaptable to new antigens. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenny, Grace, O’Reilly, Sophie R, Negi, Riya, Garcia-Leon, Alejandro, Alalwan, Dana, Gaillard, Colette Marie, Saini, Gurvin, Inzitari, Rosanna, Feeney, Eoin, Yousif, Obada, Cotter, Aoife, de Barra, Eoghan, Sadlier, Corinna, Crispie, Fiona, Doran, Peter, Gautier, Virginie, Mallon, Patrick, BCh, M B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752414/
http://dx.doi.org/10.1093/ofid/ofac492.390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752414/
http://dx.doi.org/10.1093/ofid/ofac492.390

Ejemplares similares